Rocket Pharmaceuticals (RCKT) News
NASDAQ: RCKTHealth CareBiotechnology: Pharmaceutical PreparationsUSD
2.56-0.07 (-2.66%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
RCKT news summary
We found 1 recent headline mentioning Rocket Pharmaceuticals (RCKT): 1 in the past week and 1 in the past 30 days, most often from Nasdaq. For price context, RCKT is down 2.66% at $2.56. The most recent story, "Goldman Sachs Upgrades Rocket Pharmaceuticals to Neutral from Sell", was published by Nasdaq on Oct 8, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology